Mediledger Consortium Completes FDA Pilot For Drug Tracking On Blockchain
MediLedger, a blockchain-based pharmaceutical consortium, said it completed and released the Final Pilot Report after running a pilot program for the U.S. Food and Drug Administration (FDA) that details the ways to use blockchain for drug tracking. The program was initiated in 2019 to help the industry move toward meeting the 2023 requirements of the Drug Supply Chain Security Act (DSCSA).
Source: RTTNews